GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PharmaCorp Rx Inc (TSXV:PCRX) » Definitions » Market Cap

PharmaCorp Rx (TSXV:PCRX) Market Cap : C$63.59 Mil (As of Dec. 13, 2024)


View and export this data going back to 2022. Start your Free Trial

What is PharmaCorp Rx Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PharmaCorp Rx's share price for the quarter that ended in Sep. 2024 was C$0.69. PharmaCorp Rx's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 116.95 Mil. Therefore, PharmaCorp Rx's market cap for the quarter that ended in Sep. 2024 was C$80.70 Mil.

PharmaCorp Rx's quarterly market cap increased from Mar. 2024 (C$8.46 Mil) to Jun. 2024 (C$20.29 Mil) and increased from Jun. 2024 (C$20.29 Mil) to Sep. 2024 (C$80.70 Mil).

PharmaCorp Rx's annual market cap increased from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$24.00 Mil) but then declined from Dec. 2022 (C$24.00 Mil) to Dec. 2023 (C$8.46 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PharmaCorp Rx's Enterprise Value for Today is C$37.91 Mil.


PharmaCorp Rx Market Cap Historical Data

The historical data trend for PharmaCorp Rx's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCorp Rx Market Cap Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23
Market Cap
- 24.00 8.46

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.46 8.46 8.46 20.29 80.70

Competitive Comparison of PharmaCorp Rx's Market Cap

For the Shell Companies subindustry, PharmaCorp Rx's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaCorp Rx's Market Cap Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, PharmaCorp Rx's Market Cap distribution charts can be found below:

* The bar in red indicates where PharmaCorp Rx's Market Cap falls into.



PharmaCorp Rx Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

PharmaCorp Rx's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=C$0.21*40.2784
=C$8.46

PharmaCorp Rx's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=C$0.69*116.954
=C$80.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaCorp Rx  (TSXV:PCRX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


PharmaCorp Rx Market Cap Related Terms

Thank you for viewing the detailed overview of PharmaCorp Rx's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaCorp Rx Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
Website
PharmaCorp Rx Inc foremerly Proton Capital Corp is a Capital Pool Company. The principal business of the company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.